An Evaluation of Psilocybin's Effect on Cardiac Repolarization and the Effect of Food on Psilocybin's Pharmacokinetics

The psilocybin used in this study is synthetically manufactured in a laboratory and meets quality specifications suitable for human research use. The active drug is encapsulated using a hydroxypropyl methylcellulose (HPMC) capsule and contains psilocybin (API only in a capsule).

The positive comparator used in this study is a 400 mg moxifloxacin tablet.

The placebo used in this study is encapsulated using a HPMC capsule and contains micro-crystalline cellulose.